- Home
- HNST vs FDMT Comparison
HNST vs FDMT Comparison
Compare HNST & FDMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HNST | FDMT |
|---|---|---|
| Founded | 2012 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Catalog/Specialty Distribution | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 585.8M | 695.3M |
| IPO Year | 2021 | 2019 |
Fundamental Metrics
Financial Performance| Metric | HNST | FDMT |
|---|---|---|
| Price | $4.92 | $12.06 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 7 |
| Target Price | $3.05 | ★ $31.71 |
| AVG Volume (30 Days) | ★ 2.6M | 590.6K |
| Earning Date | 05-06-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 18.79 |
| EPS | ★ 0.09 | N/A |
| Revenue | ★ $371,317,000.00 | $85,209,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $5.93 | $70.28 |
| P/E Ratio | $55.89 | ★ N/A |
| Revenue Growth | N/A | ★ 230194.60 |
| 52 Week Low | $2.07 | $5.97 |
| 52 Week High | $5.84 | $14.00 |
Technical Indicators
Market Signals| Indicator | HNST | FDMT |
|---|---|---|
| Relative Strength Index (RSI) | 64.08 | 61.51 |
| Support Level | $3.22 | $9.63 |
| Resistance Level | $5.84 | $11.89 |
| Average True Range (ATR) | 0.28 | 0.61 |
| MACD | 0.09 | 0.19 |
| Stochastic Oscillator | 57.74 | 93.42 |
Price Performance
Historical ComparisonAbout HNST The Honest Company Inc.
The Honest Co Inc is a personal care company dedicated to creating cleanly-formulated and sustainably-designed products for everyone from babies to adults. By combining thoughtful design with science-based innovation, the company delivers personal care products for everyone from babies to adults, spanning categories across wipes, personal care, diapers, and beauty. It has three product categories namely; Diapers and Wipes, Skin and Personal Care, and Household and Wellness, out of which the majority of its revenue is generated from the sale of diapers and wipes. The company operates only in the United States.
About FDMT 4D Molecular Therapeutics Inc.
4D Molecular Therapeutics Inc is biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients. Companies focus is on advancing 4D-150 for wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME) through late-stage studies. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-710 and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector).